These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 2167709)

  • 41. Subunit vaccines against exogenous retroviruses: overview and perspectives.
    Hunsmann G
    Cancer Res; 1985 Sep; 45(9 Suppl):4691s-4693s. PubMed ID: 2410114
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Use of lentivirus-like particles alone and in combination with live vaccinia-virus-based vaccines.
    Panicali DL; Mazzara G; Sullivan JL; Hesselton R; Shen L; Letvin N; Daniel M; Desrosiers R; Stott EJ
    AIDS Res Hum Retroviruses; 1992 Aug; 8(8):1449. PubMed ID: 1466979
    [No Abstract]   [Full Text] [Related]  

  • 43. Antibody-dependent enhancement and neutralization pattern of sera from SIV-infected or HIV-2-vaccinated rhesus monkeys.
    Le Grand R; Vogt G; Chapel A; Dormont D
    J Med Primatol; 1991 Jun; 20(4):172-6. PubMed ID: 1942007
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Systemic vaccination prevents the total destruction of mucosal CD4 T cells during acute SIV challenge.
    Mattapallil JJ; Hill B; Douek DC; Roederer M
    J Med Primatol; 2006 Aug; 35(4-5):217-24. PubMed ID: 16872285
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Whole inactivated SIV vaccine grown on human cells fails to protect against homologous SIV grown on simian cells.
    Putkonen P; Nilsson C; Hild K; Benthin R; Cranage M; Aubertin AM; Biberfeld G
    J Med Primatol; 1993; 22(2-3):100-3. PubMed ID: 8411101
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Simian immunodeficiency viruses.
    Desrosiers RC
    Annu Rev Microbiol; 1988; 42():607-25. PubMed ID: 2849374
    [No Abstract]   [Full Text] [Related]  

  • 47. The ability of certain SIV vaccines to provoke reactions against normal cells.
    Langlois AJ; Weinhold KJ; Matthews TJ; Greenberg ML; Bolognesi DP
    Science; 1992 Jan; 255(5042):292-3. PubMed ID: 1549775
    [No Abstract]   [Full Text] [Related]  

  • 48. Prevention of simian acquired immune deficiency syndrome with a formalin-inactivated type D retrovirus vaccine.
    Marx PA; Pedersen NC; Lerche NW; Osborn KG; Lowenstine LJ; Lackner AA; Maul DH; Kwang HS; Kluge JD; Zaiss CP
    J Virol; 1986 Nov; 60(2):431-5. PubMed ID: 3021978
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Serum capacity to inhibit reverse transcriptase in vitro distinguishes HIV-1 infection from HIV-2 or SIV infection.
    Wolfs TF; Geelen JL; Schellekens H; Barin F; Dekker JT; Goudsmit J
    AIDS Res Hum Retroviruses; 1989 Oct; 5(5):535-40. PubMed ID: 2480153
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Challenges and strategies for AIDS vaccine development.
    Oxford JS; Frezza P; Race E
    Vaccine; 1993; 11(6):612-4. PubMed ID: 8100664
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The biology and immunopathology of simian immunodeficiency virus infection.
    Fultz PN; Anderson DC
    Curr Opin Immunol; 1989-1990 Feb; 2(3):403-8. PubMed ID: 2561344
    [No Abstract]   [Full Text] [Related]  

  • 52. AIDS vaccines: is older better?
    Cohen J
    Science; 1992 Dec; 258(5090):1880-1. PubMed ID: 1470911
    [No Abstract]   [Full Text] [Related]  

  • 53. Assessing animal models of AIDS.
    Stott J; Almond N
    Nat Med; 1995 Apr; 1(4):295-7. PubMed ID: 7585052
    [No Abstract]   [Full Text] [Related]  

  • 54. AIDS research. New findings cast doubt on UK vaccine trials.
    Anderson C
    Nature; 1991 Sep; 353(6342):287. PubMed ID: 1822967
    [No Abstract]   [Full Text] [Related]  

  • 55. HIV-related lentiviruses of nonhuman primates.
    Desrosiers RC; Daniel MD; Li Y
    AIDS Res Hum Retroviruses; 1989 Oct; 5(5):465-73. PubMed ID: 2556170
    [No Abstract]   [Full Text] [Related]  

  • 56. Silent infection of macaques inoculated with low-dose SIVmac251/spl.
    Petry H; Dittmer U; Stahl-Hennig C; Jurkiewicz E; Hunsmann G; Lüke W
    AIDS Res Hum Retroviruses; 1997 Nov; 13(16):1355-6. PubMed ID: 9359653
    [No Abstract]   [Full Text] [Related]  

  • 57. Vaccination with Rev and Tat against AIDS.
    Osterhaus AD; van Baalen CA; Gruters RA; Schutten M; Siebelink CH; Hulskotte EG; Tijhaar EJ; Randall RE; van Amerongen G; Fleuchaus A; Erfle V; Sutter G
    Vaccine; 1999 Jun; 17(20-21):2713-4. PubMed ID: 10418922
    [No Abstract]   [Full Text] [Related]  

  • 58. Progress in vaccines against AIDS.
    Bolognesi DP
    Science; 1989 Dec; 246(4935):1233-4. PubMed ID: 2555922
    [No Abstract]   [Full Text] [Related]  

  • 59. ELISA for detection of antibodies to a type D retrovirus, SRV-W.
    Schultz KT; Thomas C; Toohey K; Curro T
    Viral Immunol; 1989; 2(1):47-55. PubMed ID: 2545226
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Strategy for developing a genetically-engineered whole-virus vaccine against HIV.
    Haynes JR; Yao FL; Ma J; Cao SX; Klein MH
    Mol Immunol; 1991 Mar; 28(3):231-4. PubMed ID: 2017194
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.